Cancer Genetics Prices Public Offering, Moves to Nasdaq | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer Genetics today announced the public offering of 1.5 million shares of its common stock at $10 per share and the migration of its stock to the Nasdaq Capital Market.

Its stock had been trading on the OTC QB since the company went public in April.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.